LifeMap Sciences ("LifeMap") is a life sciences technology company that develops and commercializes innovative Next Generation Sequencing (“NGS”) analysis solutions and tools, as well as the company’s core technology, the GeneCards Suite® Knowledgebase, to improve biomedical research & healthcare.
LifeMap offers TGex™ (Translational Genomics Expert), an integrated, end-to-end analysis solution for NGS data providing streamlined interpretation and reporting. TGex empowers NGS analysis by highlighting associations between genes and phenotypes, providing supporting evidence for immediate evaluation and automatically generating case reports. TGex is powered by the GeneCards Suite Knowledgebase and premium tools, which integrate information from over 120 sources and enable researchers to effectively navigate the universe of human genes, genetic variants, proteins, cells, biological pathways, diseases, and the relationships between them.
LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biopharma and diagnostic companies and has been successfully marketed for 12 years. LifeMap holds the exclusive worldwide license to market GeneCards Suite products from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science. Operations worldwide are carried out from our offices in New Jersey, California, Massachusetts, Tel Aviv and Hong Kong.
LifeMap is a subsidiary of BioTime, Inc (NYSE MKT and TASE: BTX). LifeMap Sciences also intends to extend its offerings to the field of mobile health (mHealth) via its subsidiary, LifeMap Solutions, Inc.
P: +972 3 9118436
P: +852 9546-3490